• Wed, May 21, 2025
  • Thu, May 22, 2025
  • Fri, May 23, 2025
  • Sat, May 24, 2025
  • Sun, May 25, 2025
  • Mon, May 26, 2025
  • Tue, May 27, 2025

When the FDA requires a large vaccine trial, who pays?

And more must-read biotech news brought to you by The Readout.
The article from STAT News dated May 20, 2025, discusses several key developments in the biotech industry. Pfizer has acquired Tourmaline Bio for $1.5 billion, aiming to bolster its immunology portfolio. Novavax is facing challenges with its Covid-19 vaccine, reporting a significant drop in sales and contemplating strategic alternatives. Prime Medicine has received FDA clearance for its first clinical trial using prime editing technology, marking a significant step in gene editing. Additionally, the FDA has approved a new CRISPR-based therapy for sickle cell disease, highlighting advancements in genetic treatments. The article also touches on the ongoing debate over vaccine mandates and the impact of recent court rulings on public health policies.

Read the Full STAT Article at:
https://www.statnews.com/2025/05/20/biotech-news-pfizer-tourmaline-novavax-prime-crispr-fda-vaccines-the-readout/

Like: 👍